NuCana plc (NCNA:NASDAQ) closed at $0.990 on October 16, 2026, down 2.93% on the day. The stock trades 82.5% below its 52-week high of $5.65 and 4.4% above its 52-week low of $0.948. Over the past year, it lost 80.5%. NuCana plc is part of the Health Care sector (Major Pharmaceuticals).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -8.32% | -25.56% | -24.42% | -56.76% | -80.47% |
In 252 trading sessions since October 16, 2025, NCNA closed higher on 98 days (39%). Its best day was April 7, 2026 (+22.02%) and its worst was August 31, 2026 (-16.48%). The stock moved 10% or more in a single session 11 times.
NuCana PLC is a clinical-stage biopharmaceutical company. It is focused on improving treatment outcomes for cancer patients by applying its ProTide technology.
Find more stocks like NCNA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.